STOCK TITAN

Interparfums raises 2026 sales outlook to $1.49B

Quarterly operating income rose 9%, while the company lifted its 2026 sales target and kept EPS guidance at $4.85.

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Very High)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
8-K

Rhea-AI Filing Summary

Interparfums, Inc. (IPAR) reported third-quarter net sales of $430 million, flat year over year, while operating income rose 9% to $118 million and diluted EPS increased 4% to $2.13. Gross margin expanded 360 basis points to 67.1%. For the first nine months, sales were $1.115 billion, up 1%, and net income attributable to Interparfums was $142 million, up 1%.

The company raised 2026 sales guidance from $1.48 billion to $1.49 billion and maintained diluted EPS guidance of $4.85. Operating cash flow for the first nine months reached $102 million, compared with $68 million in the prior-year period. In the third quarter, Interparfums invested approximately $50 million to acquire additional shares of its majority-owned subsidiary Interparfums SA, raising its ownership from approximately 72.5% to 74.3%; it continues to control and consolidate the subsidiary. A regular quarterly cash dividend of $0.80 per share is payable December 31, 2026, to shareholders of record December 15, 2026.

2 points · 0 major

How this balance works

Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.

It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.

Rhea-AI Sentiment measures something else, the tone of the wording.

0 major · 0 points

How the balance works

Positive

  • Moderate pointThird-quarter operating income increased 9% to $118 million.
  • Moderate pointNine-month operating cash flow was $102 million, versus $68 million a year earlier.

Negative

  • None.

Filing Explained

The maintained 2026 EPS outlook includes tariff refunds: as of September 30, 2026, $16.4 million of about $17.7 million in estimated paid tariffs had been recognized, and most of the remaining $1.4 million was expected in the fourth quarter.

Item 2.02 Results of Operations and Financial Condition Financial
Disclosure of earnings results, typically an earnings press release or preliminary financials.
Item 7.01 Regulation FD Disclosure Disclosure
Material non-public information disclosed under Regulation Fair Disclosure, often investor presentations or guidance.
Item 8.01 Other Events Other
Voluntary disclosure of events the company deems important to shareholders but not covered by other items.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, or exhibit attachments filed with this report.
Third-quarter net sales $430 million Three months ended September 30, 2026; flat compared with 2025.
Third-quarter operating income $118 million Three months ended September 30, 2026; up 9% from $109 million in 2025.
Third-quarter gross margin 67.1% Three months ended September 30, 2026; up 360 basis points from 63.5% in 2025.
Third-quarter diluted EPS $2.13 per share Three months ended September 30, 2026; up 4% from $2.05 in 2025.
Nine-month operating cash flow $102 million Nine months ended September 30, 2026; compared with $68 million in 2025.
2026 sales guidance $1.49 billion Raised from $1.48 billion.
Quarterly cash dividend $0.80 per share Payable December 31, 2026, to shareholders of record December 15, 2026.
cash conversion financial
"improvements in cash conversion and inventory efficiency"
Cash conversion describes how quickly and efficiently a business turns its sales or accounting profits into actual, usable cash on hand. Think of it like how fast a farmer can harvest crops and sell them for cash — faster conversion means the company can pay bills, invest, or reduce debt sooner, while slower conversion can signal tight liquidity and greater financial risk for investors.
organic decline financial
"reflecting organic decline of 1%"
IEEPA tariff refunds financial
"one-time IEEPA tariff refunds of $7.9 million"
Refunds under the International Emergency Economic Powers Act (IEEPA) are repayments of import duties, fees, or penalties that were charged because of trade restrictions or sanctions put in place under emergency authority and later reversed, modified, or found inapplicable. For investors, these refunds can change a company’s past cash outflows and future cost structure—similar to getting a billed charge returned after a rule change—affecting reported earnings or cash available for other uses.
working capital financial
"working capital of $731 million"
Working capital is the money a business has available to cover its daily expenses, like paying bills and buying supplies. It’s like the cash in your wallet that helps you handle everyday costs; having enough ensures the business can operate smoothly without running into money shortages.
noncontrolling interest financial
"Net income attributable to the noncontrolling interests"
The portion of a business owned by investors other than the controlling owner when one company has control of another; it represents outside shareholders’ share of the subsidiary’s assets and profits. For investors, it matters because those outside claims reduce the amount of profit and net assets attributable to the parent owner — similar to saying part of a pizza belongs to someone else — and thus affects earnings, book value and valuation.
Third-quarter net sales $430 million flat
Third-quarter diluted EPS $2.13 per share +4%
Nine-month net sales $1.115 billion +1%
Nine-month diluted EPS $4.43 per share +2%
Guidance

2026 sales outlook increased from $1.48 billion to $1.49 billion; diluted EPS guidance maintained at $4.85.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What were IPAR's third-quarter 2026 sales and diluted EPS?

Interparfums reported third-quarter 2026 net sales of $430 million and diluted EPS of $2.13. Sales were flat compared with the year-earlier quarter, while diluted EPS was up 4% from $2.05.

What is IPAR's 2026 sales and EPS guidance?

Interparfums raised its 2026 sales outlook from $1.48 billion to $1.49 billion and maintained diluted EPS guidance at $4.85. The EPS guidance includes the expected effect of refunds already received associated with approximately $17.7 million of estimated IEEPA tariffs paid.

Why did IPAR's gross margin expand in the third quarter of 2026?

Interparfums said the increase reflected favorable segment, brand and channel mix and lower-than-expected destruction costs driven by inventory efficiency programs, partially offset by higher tariff expenses. Gross margin also benefited from $7.9 million in one-time IEEPA tariff refunds in the quarter.

How did IPAR sales change by region in the first nine months of 2026?

Sales increased 4% in North America, 12% in Asia/Pacific and 12% in Central and South America. They declined 3% in Western Europe, 15% in Eastern Europe and 19% in the Middle East and Africa.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
NY false 000082266300008226632026-11-042026-11-04

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

 Date of Report (Date of Earliest Event Reported): November 4, 2026 

 
Interparfums, Inc.
(Exact name of Registrant as specified in its charter)

 

Delaware

 

0-16469

 

13-3275609

(State or other jurisdiction of
incorporation or organization)

 

Commission
File Number

 

(I.R.S. Employer
Identification No.)

 

551 Fifth Avenue, New York, NY 10176
(Address of Principal Executive Offices)

 

212.983.2640
(Registrant’s Telephone number, including area code)

 

   (Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions (see General Instruction A.2 below):

 

☐

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

☐

Soliciting Material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

☐

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

☐

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

 

Trading Symbol(s)

 

Name of each exchange
on which registered

 

 

 

 

 

 Common Stock, $.001 par value per share

 

IPAR

 

The Nasdaq Stock Market

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 


Item 2.02 Results of Operations and Financial Conditions

 

Certain portions of our press release dated November 4, 2026, a copy of which is annexed hereto as Exhibit no. 99.1, are incorporated by reference herein, and are filed pursuant to this Item 2.02. They are as follows:

 

         The 1st, 2nd (consisting of a table), 9th through 12th full paragraphs relating to net sales and operations for the third quarter and nine (9) months ended September 30, 2026

         Portions of the 3rd paragraph relating to net sales for the third quarter and nine (9) months ended September 30, 2026

         The 4th through 6th paragraphs relating to sales by territory for the first nine months of 2026

         Portions of the 3rd, 7th, and 8th  paragraphs relating to net sales

         Portions of the 13th paragraph  relating to operations for the third quarter and nine (9) months ended September 30, 2026

         The 14th, 15th and 16th full paragraphs relating to Company operations for the third quarter and nine (9) months ended September 30, 2026

         The  17th full paragraph relating to the balance sheet

         The 18th and 19th full paragraphs relating to the Company’s share repurchases and strategy for the third quarter of 2026

         Portions of the 20th paragraph relating to tariff refunds

         The 23rd through 26th paragraphs relating to the previously announced conference call for the 2026 third quarter results

         The unaudited consolidated statements of income and consolidated balance sheets

 

Item 7.01 Regulation FD Disclosure

 

Certain portions of our press release dated November 4, 2026, a copy of which is annexed hereto as Exhibit no. 99.1, are incorporated by reference herein, and are filed pursuant to this Item 7.01. They are as follows:

 

         Portions of the 3rd paragraph concerning the Company’s outlook for 2026-2028.

         Portions of the 7th paragraph relating to future fragrance debuts from Longchamp, Off-White and PUMA in 2027

         Portions of the 20th paragraph relating to increasing the 2026 guidance

         The 21st paragraph relating to initial 2027 guidance issuance date

         The 29th paragraph relating to forward-looking information

         The balance of such press release not otherwise incorporated by reference in 2.02

 

Item 8.01 Other Events

 

The 22nd paragraph relating to dividends

 

Item 9.01 Financial Statements and Exhibits.

 

99.1

Our press release dated November 4, 2026

 


SIGNATURES

 

Pursuant to the requirements of the Securities and Exchange Act of 1934, the Registrant has duly caused and authorized this report to be signed on its behalf by the undersigned.

 

Dated: November 4, 2026

 

 

Interparfums, Inc.

 

 

 

By:

/s/ Michel Atwood

 

 

Michel Atwood,

 

 

Chief Financial Officer

 


 

Exhibit 99.1

 

Graphics

 

FOR IMMEDIATE RELEASE

 

INTERPARFUMS, INC. REPORTS 2026 THIRD QUARTER AND NINE-MONTH RESULTS;

RAISES FULL YEAR SALES GUIDANCE AND REAFFIRMS EARNINGS OUTLOOK

 

Third Quarter Net Sales of $430 Million with Diluted EPS of $2.13; Nine-Month Sales Increased to $1.1 Billion with Diluted EPS of $4.43

Quarterly Cash Dividend of $0.80 Per Share to be Paid on December 31, 2026

 

New York, New York, November 4, 2026, Interparfums, Inc. (NASDAQ GS: IPAR) (“Interparfums” or the “Company”) today reported results for the third quarter and nine months ended September 30, 2026.

 

Financial Highlights:

($ in millions, except per share amounts)

Three Months Ended September 30,

Nine Months Ended September 30,

2026

2025

% Change

2026

2025

% Change

Net Sales

$430

$430

flat

$1,115

$1,102

+1%

Gross Margin

67.1%

63.5%

+360 bps

66.0%

64.4%

+160 bps

Operating Income

$118

$109

+9%

$241

$243

(1%)

Operating Margin

27.4%

25.3%

+210 bps

21.6%

22.0%

(40) bps

Net Income attributable to Interparfums, Inc.

$68

$66

+4%

$142

$140

+1%

Diluted EPS

$2.13

$2.05

+4%

$4.43

$4.36

+2%

The average dollar/euro exchange rate for the 2026 third quarter was 1.15 compared to 1.17 in the 2025 third quarter, leading to a 0.4% foreign exchange loss. For the first nine months, the average dollar/euro exchange rate was 1.16 compared to 1.12 in the first nine months of 2025, leading to a 1.5% foreign exchange gain.

Data may not foot due to rounding

 

Operational Commentary

Jean Madar, Chairman & Chief Executive Officer of Interparfums, stated, “Our results for the third quarter and nine months reflect multiple drivers, primary among them our global portfolio which allows us to support overall performance by capturing opportunities where consumer demand remains healthy while simultaneously mitigating the effect of challenging conditions in certain of our markets. The hard work of our team is driving meaningful progress across the Company through key operational and financial initiatives, as well as brand innovation and investment. These activities are strengthening our execution and positioning us for a strong finish to 2026 with continued optimism for 2027and 2028, as we prepare for a series of blockbuster releases across our brand portfolio.

 

“Growth across key brands and markets in the first nine months of 2026 demonstrated the resilience of our business model, as gains in North America, Asia/Pacific and Central and South America offset softer demand and operational and geopolitical challenges in other regions, including Eastern Europe and the Middle East. Sales in North America, our largest market, rose 4%, driven by continued market growth, the launch of several extensions, particularly for Coach, as well as successful marketing and advertising investments. Asia/Pacific sales increased 12% primarily due to brand initiatives with Coach and Jimmy Choo, the expansion of Ferragamo and GUESS, and continued success of our new affiliate in Korea that opened in late 2025. Central and South America net sales increased 12% thanks to the success of women’s and men’s Coach franchises, as well as the strength of the Montblanc Legend line and robust growth from Jimmy Choo.

 

“Growth through the first nine months of 2026 was partially offset by declines of 3% in Western Europe amid softer consumer demand, 15% in Eastern Europe due to operational challenges that disproportionately affected Lanvin and Lacoste, and 19% in the Middle East and Africa, primarily reflecting the ongoing war in the Middle East.

 

“By brand, year to date sales grew across several of our key franchises and geographies. For brands managed by our European based operations, Coach increased 15%, Jimmy Choo rose 5%, and Montblanc grew 8%. While Lacoste sales declined 9% year to date, the brand returned to growth in the third quarter, rising 4%, after a challenging first half that reflected a strong prior year comparison due to robust innovation and softer conditions in Eastern Europe. For brands managed by our United States based operations, GUESS grew 7%, Donna Karan/DKNY rose 4%, and Roberto Cavalli grew 6%. Ferragamo sales declined 2%, reflecting challenging market conditions in Europe, which is the core region for the brand.”

 

1



 

Continued Portfolio-Wide Innovation and Expansion

Mr. Madar continued, “We have continued to scale our brand reach and capture new audiences through line extensions across our portfolio. During the 2026 third quarter, these included: Jimmy Choo, I Want Choo Midnight for women; Montblanc, Explorer Infinite for men; Lacoste, Original Intense for women; and DKNY, Women Skyline. Our extension-driven launch strategy is building momentum into 2027, with additional extensions due before year-end 2026, a diverse pipeline of introductions from our core brands, and fragrance debuts from our newest brands Longchamp, Off-White and PUMA.”

 

Closing Remarks

Mr. Madar concluded, “Our execution throughout this year highlights the resilience of our premier fragrance portfolio as we successfully manage evolving market dynamics. By keeping our brand partners, retailers, and global consumers at the heart of our operations, we continue to capture meaningful global demand. We believe that our emphasis on maximizing productivity alongside targeted marketing investments will support our ability to drive sustained, profitable growth in 2027 and 2028.”

 

Financial Commentary

Michel Atwood, Chief Financial Officer of Interparfums, noted, “Through the first nine months of the year, we delivered measured top-line growth, expanded gross margins, and generated higher net income while investing in the success of our brands and driving further improvements in cash conversion and inventory efficiency. Our disciplined cash management and capital allocation strategy has enabled us to amass significant cash balances, positioning the Company to continue returning capital to shareholders and providing the flexibility to potentially acquire one or more brands, either on a proprietary basis or as a licensee should the opportunity materialize.”

 

Consolidated sales growth in the third quarter was flat on a reported and organic basis. Sales rose 1% for the first nine months of 2026, reflecting organic decline of 1% offset by positive impacts from new brands and favorable foreign exchange dynamics. The ongoing war in the Middle East represented a headwind of 1% in the third quarter and 2% for the first nine months of this year.

 

Consolidated gross margin in the third quarter and first nine months of 2026 expanded by 360- and 160-basis points to 67.1% and 66.0%, respectively. These increases were the result of favorable segment, brand and channel mix as well as lower than expected destruction costs driven by our inventory efficiency programs, which were partially offset by higher tariff expenses. Gross margin also benefited from one-time IEEPA tariff refunds of $7.9 million in the third quarter of 2026 and $14.8 million for the first nine months of 2026.

 

Selling, General and Administrative expenses (“SG&A”) as a percentage of sales rose to 39.7% and 44.4% in the third quarter and first nine months of 2026, respectively, compared to 38.2% and 42.4% during the prior year periods. The increases were primarily due to higher brand marketing investments, royalty costs growing ahead of sales driven by an unfavorable brand mix, and higher logistics costs related to supply chain transitions and channel mix.

 

Advertising and promotional (“A&P”) expenses in the third quarter and first nine months of 2026 totaled $65 million and $194 million, representing 15.1% and 17.4% of sales, compared to 15.3% and 16.9% of sales during the respective prior year periods. As shared last quarter, we are reinvesting the tariff refunds to support the strong momentum we are seeing in the United States market, drive our top-line growth and position the Company for a successful 2027; as such, we anticipate our full year 2026 A&P expenditures will approach our long-term target of approximately 21% of net sales.

 

The metrics mentioned resulted in the 2026 third quarter operating margin expanding 210-basis points to 27.4% from 25.3%, although operating margin year to date was 21.6% compared to 22.0% in the prior year period.

 

Our consolidated effective tax rate was 24.6% for the nine months ended September 30, 2026 compared to 23.5% in the prior year period, which was helped by a $2 million one-time gain in the prior period.

 

Third quarter net income rose 4% to $68 million, or $2.13 per diluted share, compared to $66 million or $2.05 per share in the prior year period. Net income for the first nine months of 2026 increased 1% to $142 million from $140 million, and diluted EPS rose 2% to $4.43 compared to $4.36 a year ago. As a percentage of sales, net income expanded to 15.9% in Q3 2026 and remained stable at 12.7% for the first nine months of 2026.

 

Strengthened Financial Position, Cash Conversion, and Efficiency

Mr. Atwood continued, “As of September 30, 2026, we reported $240 million in cash, cash equivalents and short-term investments, and working capital of $731 million. We continued to enhance our cash conversion in the first nine months of 2026, with operating cash flow reaching $102 million, or 56% of net income, up from $68 million, or 38% of net income, in the prior year period. We reduced total inventory levels by 3% compared to the prior year period, translating to a reduction of 16 days inventory on hand as we continue to drive inventory efficiencies and work to increase conversion of raw materials into finished goods. Long-term debt, excluding current maturities, approximated $147 million.”

 

Share Repurchase

In July 2026, the Board of Directors of our Company authorized a share repurchase program to purchase outstanding shares in either our Company (IPAR) or its majority owned Paris based subsidiary, Interparfums SA, whose shares trade on the Euronext under the symbol “ITP,” or both.

 

During the third quarter of 2026, the Company invested approximately $50 million to acquire additional shares of Interparfums SA under this program, increasing its ownership interest from approximately 72.5% to 74.3%. The Company continues to control and consolidate Interparfums SA, and the purchases and related costs were accounted for as equity transactions.

 

2



Increases 2026 Sales Guidance, Maintains EPS Outlook

The Company is increasing its 2026 sales outlook from $1.48 billion to $1.49 billion and maintaining EPS of $4.85. EPS guidance for 2026 includes the expected effect of refunds already received associated with approximately $17.7 million of estimated IEEPA tariffs paid by the Company. As of September 30, 2026, the Company has recognized $16.4 million of these refunds in its Condensed Consolidated Statements of Income, with the majority of the remaining $1.4 million expected to be realized in the current fourth quarter.

 

Interparfums plans to release its initial guidance for full-year 2027 on Wednesday, November 18, 2026, after the close of the market.

 

Dividend

The Company’s regular quarterly cash dividend of $0.80 per share will be paid on December 31, 2026 to shareholders of record on December 15, 2026.

 

Conference Call

Management will host a conference call to discuss financial results and business operations beginning at 11:00 am ET on Thursday, November 5, 2026

 

Interested parties may participate in the live call by dialing:

U.S. / Toll-free: (877) 423-9820

International: (201) 493-6749

 

Participants are asked to dial-in approximately 10 minutes before the conference call is scheduled to begin.

A live audio webcast will also be available in the “Events” tab within the Investor Relations section of the Company’s website at www.interparfumsinc.com, or by clicking here. The conference call will be available for webcast replay for approximately 90 days following the live event.

 

About Interparfums, Inc.:

Operating in the global fragrance business since 1982, Interparfums, Inc. produces and distributes a wide array of prestige fragrance and fragrance related products under license and other agreements with brand owners. The Company manages its business in two operating segments, European based operations, through its 74% owned subsidiary, Interparfums SA, and United States based operations, through wholly owned subsidiaries in the United States and Italy.

 

Our licensed portfolio of prestige brands includes Abercrombie & Fitch, Anna Sui, Boucheron, Coach, Donna Karan/DKNY, Emanuel Ungaro, Ferragamo, Graff, GUESS, Hollister, Jimmy Choo, Karl Lagerfeld, Kate Spade, Lacoste, Longchamp, MCM, Moncler, Montblanc, Oscar de la Renta, PUMA, Roberto Cavalli, and Van Cleef & Arpels, whose products are distributed in over 120 countries around the world through an extensive and diverse network of distributors. Interparfums, Inc. is also the registered owner of several trademarks including Annick Goutal, Lanvin, Off-White, Rochas, and Solférino.

 

Forward-Looking Statements:

Statements in this release which are not historical in nature are forward-looking statements. Although we believe that our plans, intentions, and expectations reflected in such forward-looking statements are reasonable, we can give no assurance that such plans, intentions, or expectations will be achieved. In some cases, you can identify forward-looking statements by forward-looking words such as “anticipate,” “believe”, “could”, “estimate”, “expect”, “intend”, “may”, “should”, “will”, and “would” or similar words. You should not rely on forward-looking statements, because actual events or results may differ materially from those indicated by these forward-looking statements as a result of a number of important factors. These factors include, but are not limited to, the risks and uncertainties discussed under the headings “Forward Looking Statements” and “Risk Factors” in Interparfums' annual report on Form 10-K for the fiscal year ended December 31, 2025, and the reports Interparfums files from time to time with the Securities and Exchange Commission. Interparfums does not intend to and undertakes no duty to update the information contained in this press release.

 

Contact Information:

 

Interparfums, Inc.

or

The Equity Group Inc.

Michel Atwood

 

Devin Sullivan: (212) 836-9608 / devin.sullivan@theequitygroup.com

Chief Financial Officer

 

Conor Rodriguez: (212) 836-9628 / conor.rodriguez@theequitygroup.com

(212) 983-2640

 

www.theequitygroup.com

www.interparfumsinc.com

 

 

 

See Accompanying Tables

 

3



INTERPARFUMS, INC. AND SUBSIDIARIES

 

CONDENSED CONSOLIDATED BALANCE SHEETS

 (In thousands except share and per share data)

 (Unaudited)

 

Assets

 September 30, 2026

 

 December 31, 2025

Current assets:

 

 

 

 

 

Cash and cash equivalents

$

131,912

 

$

158,091

Short-term investments

 

108,334

 

 

137,093

Accounts receivable, net

 

375,407

 

 

320,625

Inventories

 

376,154

 

 

351,377

Receivables, other

 

7,246

 

 

9,014

Other current assets

 

45,102

 

 

39,954

Income taxes receivable

 

122

 

 

11,211

Total current assets

 

1,044,277

 

 

1,027,365

Property, equipment and leasehold improvements, net

 

174,434

 

 

184,891

Right-of-use assets, net

 

19,358

 

 

23,347

Trademarks, licenses and other intangible assets, net

 

308,258

 

 

325,185

Deferred tax assets

 

9,037

 

 

4,234

Other assets

 

21,032

 

 

20,226

Total assets

$

1,576,396

 

$

1,585,248

 

 

 

 

 

 

Liabilities and Equity

 

 

 

 

 

Current liabilities:

 

 

 

 

 

Loans payable - banks

$

3,974

 

$

9,400

Current portion of long-term debt

 

43,084

 

 

54,774

Current portion of lease liabilities

 

6,142

 

 

6,326

Accounts payable – trade

 

81,111

 

 

77,210

Accrued expenses

 

168,018

 

 

189,622

Income taxes payable

 

10,917

 

 

6,671

Total current liabilities

 

313,246

 

 

344,003

Long–term debt, less current portion

 

147,381

 

 

121,254

Lease liabilities, less current portion

 

11,557

 

 

15,967

Deferred tax liabilities

 

1,608

 

 

—

Total liabilities

$

473,792

 

$

481,224

 

 

 

 

 

 

Equity:

 

 

 

 

 

Interparfums, Inc. shareholders’ equity:

 

 

 

 

 

Preferred stock, $.001 par; authorized 1,000,000 shares; none issued and outstanding

 

—

 

 

—

Common stock, $.001 par; authorized 100,000,000 shares; issued 41,105,825 and 41,100,125 and outstanding 32,026,981 and 32,067,285 shares at September 30, 2026 and December 31, 2025, respectively

 

32

 

 

32

Additional paid-in capital

 

95,227

 

 

127,541

Retained earnings

 

881,169

 

 

828,906

Accumulated other comprehensive loss

 

(27,293)

 

 

(9,029)

Treasury stock, at cost, 9,078,844 and 9,032,840 shares at September 30, 2026 and December 31, 2025, respectively

 

(70,670)

 

 

(66,734)

Total Interparfums, Inc. shareholders’ equity

 

878,465

 

 

880,716

Noncontrolling interest

 

224,139

 

 

223,308

Total equity

 

1,102,604

 

 

1,104,024

Total liabilities and equity

$

1,576,396

 

$

1,585,248

 

 

4



INTERPARFUMS, INC. AND SUBSIDIARIES

 

CONDENSED CONSOLIDATED STATEMENTS OF INCOME

(In thousands except per share data)

 (Unaudited)

 

 

Three Months Ended September 30,

 

Nine Months Ended September 30,

 

2026

 

2025

 

2026

 

2025

 

 

 

 

 

 

 

 

 

 

 

 

Net sales

$

429,508

 

$

429,579

 

$

1,115,430

 

$

1,102,334

 

 

 

 

 

 

 

 

 

 

 

 

Cost of sales

 

141,312

 

 

156,762

 

 

379,070

 

 

392,451

 

 

 

 

 

 

 

 

 

 

 

 

Gross margin

 

288,196

 

 

272,817

 

 

736,360

 

 

709,883

 

 

 

 

 

 

 

 

 

 

 

 

Selling, general and administrative expenses

 

170,322

 

 

164,261

 

 

495,411

 

 

467,074

 

 

 

 

 

 

 

 

 

 

 

 

Income from operations

 

117,874

 

 

108,556

 

 

240,949

 

 

242,809

 

 

 

 

 

 

 

 

 

 

 

 

Other expenses (income):

 

 

 

 

 

 

 

 

 

 

 

Interest expense

 

1,554

 

 

2,305

 

 

4,445

 

 

5,637

Gain (loss) on foreign currency

 

(331)

 

 

2,215

 

 

(162)

 

 

4,576

Interest and investment income

 

(1,314)

 

 

(2,547)

 

 

(4,322)

 

 

(1,199)

Other loss (income)

 

514

 

 

(978)

 

 

85

 

 

(1,302)

 

 

 

 

 

 

 

 

 

 

 

 

Income before income taxes

 

117,451

 

 

107,561

 

 

240,903

 

 

235,097

 

 

 

 

 

 

 

 

 

 

 

 

Income taxes

 

29,275

 

 

24,282

 

 

59,142

 

 

55,218

 

 

 

 

 

 

 

 

 

 

 

 

Net income

 

88,176

 

 

83,279

 

 

181,761

 

 

179,879

 

 

 

 

 

 

 

 

 

 

 

 

Less:  Net income attributable to the noncontrolling interests

 

19,973

 

 

17,470

 

 

39,705

 

 

39,590

 

 

 

 

 

 

 

 

 

 

 

 

Net income attributable to Interparfums, Inc. common shareholders

$

68,203

 

$

65,809

 

$

142,056

 

$

140,289

 

 

 

 

 

 

 

 

 

 

 

 

Earnings per share:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income attributable to Interparfums, Inc. common shareholders:

 

 

 

 

 

 

 

 

 

 

 

Basic

$

2

 

$

2.05

 

$

4.44

 

$

4.37

Diluted

$

2

 

$

2.05

 

$

4.43

 

$

4.36

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average number of shares outstanding:

 

 

 

 

 

 

 

 

 

 

 

Basic

 

32,026

 

 

32,113

 

 

32,027

 

 

32,114

Diluted

 

32,039

 

 

32,149

 

 

32,031

 

 

32,158

 

 

 

 

 

 

 

 

 

 

 

 

Dividends declared per share

$

0.80

 

$

0.80

 

$

2.40

 

$

2.40

 

5


 

Filing Exhibits & Attachments

6 documents

Keep reading